David Y. Léger

2.1k total citations
57 papers, 1.8k citations indexed

About

David Y. Léger is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, David Y. Léger has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Biomedical Engineering. Recurrent topics in David Y. Léger's work include Photodynamic Therapy Research Studies (14 papers), Nanoplatforms for cancer theranostics (12 papers) and Phytochemical Studies and Bioactivities (10 papers). David Y. Léger is often cited by papers focused on Photodynamic Therapy Research Studies (14 papers), Nanoplatforms for cancer theranostics (12 papers) and Phytochemical Studies and Bioactivities (10 papers). David Y. Léger collaborates with scholars based in France, Lebanon and Switzerland. David Y. Léger's co-authors include Bertrand Liagre, Jean‐Louis Beneytout, Vincent Sol, Frédérique Brégier, Vincent Chaleix, Mohamed Hmamouchi, Robert Granet, Aline Pinon, Bruno Therrien and Youness Limami and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

David Y. Léger

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Y. Léger France 25 748 316 249 228 212 57 1.8k
Li Ren China 21 592 0.8× 363 1.1× 219 0.9× 83 0.4× 293 1.4× 87 1.7k
Yongbo Peng China 32 1.4k 1.9× 477 1.5× 193 0.8× 122 0.5× 179 0.8× 111 2.6k
Xuemei Huang China 24 795 1.1× 173 0.5× 202 0.8× 133 0.6× 130 0.6× 70 2.1k
Bertrand Liagre France 31 1.6k 2.1× 372 1.2× 503 2.0× 259 1.1× 255 1.2× 107 3.1k
Jianfang Feng China 27 785 1.0× 223 0.7× 484 1.9× 100 0.4× 103 0.5× 68 1.9k
Tiange Cai China 23 736 1.0× 354 1.1× 526 2.1× 124 0.5× 111 0.5× 49 1.9k
Hui Yu China 24 965 1.3× 331 1.0× 249 1.0× 129 0.6× 198 0.9× 97 1.9k
Jia Zhang China 27 1.2k 1.6× 291 0.9× 280 1.1× 206 0.9× 188 0.9× 138 2.7k
Haiyun Li China 27 864 1.2× 148 0.5× 120 0.5× 111 0.5× 167 0.8× 90 2.1k
Chao Han China 30 1.4k 1.9× 367 1.2× 142 0.6× 158 0.7× 151 0.7× 121 2.8k

Countries citing papers authored by David Y. Léger

Since Specialization
Citations

This map shows the geographic impact of David Y. Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y. Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y. Léger more than expected).

Fields of papers citing papers by David Y. Léger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Y. Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y. Léger. The network helps show where David Y. Léger may publish in the future.

Co-authorship network of co-authors of David Y. Léger

This figure shows the co-authorship network connecting the top 25 collaborators of David Y. Léger. A scholar is included among the top collaborators of David Y. Léger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Y. Léger. David Y. Léger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrion, Claire, et al.. (2023). The Effect of Photosensitizer Metalation Incorporated into Arene–Ruthenium Assemblies on Prostate Cancer. International Journal of Molecular Sciences. 24(17). 13614–13614. 5 indexed citations
2.
Granet, Robert, Jean‐Pierre Mbakidi, Ludovic Bretin, et al.. (2021). Design and synthesis of zinc protoporphyrin IX-adamantane/cyclodextrin/cellulose nanocrystals complexes for anticancer photodynamic therapy. Bioorganic & Medicinal Chemistry Letters. 41. 128024–128024. 15 indexed citations
3.
Léger, David Y., Soumaya Nasri, Frédérique Brégier, et al.. (2017). In vitro anticancer activity of new gold(III) porphyrin complexes in colon cancer cells. Journal of Inorganic Biochemistry. 177. 27–38. 27 indexed citations
4.
5.
Granet, Robert, Jean‐Pierre Mbakidi, Frédérique Brégier, et al.. (2016). Delivery of tanshinone IIA and α-mangostin from gold/PEI/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy. Bioorganic & Medicinal Chemistry Letters. 26(10). 2503–2506. 40 indexed citations
6.
Granet, Robert, Frédérique Brégier, David Y. Léger, et al.. (2015). Development of curcumin–cyclodextrin/cellulose nanocrystals complexes: New anticancer drug delivery systems. Bioorganic & Medicinal Chemistry Letters. 26(3). 941–945. 160 indexed citations
7.
Léger, David Y., Marion Millot, F. Martin, et al.. (2015). Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis. International Journal of Oncology. 47(1). 220–230. 17 indexed citations
8.
Léger, David Y., et al.. (2013). Cyclopamine and jervine induce COX-2 overexpression in human erythroleukemia cells but only cyclopamine has a pro-apoptotic effect. Experimental Cell Research. 319(7). 1043–1053. 24 indexed citations
9.
Limami, Youness, Christelle Pouget, David Y. Léger, et al.. (2013). Novel methylsulfonyl chalcones as potential antiproliferative drugs for human prostate cancer: Involvement of the intrinsic pathway of apoptosis. International Journal of Oncology. 43(4). 1160–1168. 15 indexed citations
10.
Janoušková, Hana, David Y. Léger, Fanny Noulet, et al.. (2012). Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma. Cancer Research. 72(14). 3463–3470. 104 indexed citations
11.
Limami, Youness, Aline Pinon, David Y. Léger, et al.. (2012). The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie. 94(8). 1754–1763. 61 indexed citations
12.
Limami, Youness, Aline Pinon, David Y. Léger, et al.. (2011). HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death. Biochimie. 93(4). 749–757. 44 indexed citations
13.
Léger, David Y., et al.. (2010). Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Letters. 301(2). 193–202. 112 indexed citations
14.
Léger, David Y., et al.. (2010). Antiproliferative effect of extracts fromAristolochia baeticaandOriganum compactumon human breast cancer cell line MCF-7. Pharmaceutical Biology. 48(3). 269–274. 50 indexed citations
15.
Léger, David Y., et al.. (2009). Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF‐7 cells. Fundamental and Clinical Pharmacology. 23(5). 549–556. 95 indexed citations
16.
Léger, David Y., Serge Battu, Bertrand Liagre, Philippe Cardot, & Jean‐Louis Beneytout. (2007). Sedimentation field flow fractionation to study human erythroleukemia cell megakaryocytic differentiation after short period diosgenin induction. Journal of Chromatography A. 1157(1-2). 309–320. 18 indexed citations
17.
Léger, David Y., Bertrand Liagre, & Jean‐Louis Beneytout. (2006). Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents. APOPTOSIS. 11(10). 1747–1760. 25 indexed citations
18.
Bégaud, Gaëlle, Serge Battu, Bertrand Liagre, et al.. (2006). Pre-apoptotic sub-population cell sorting from diosgenin apoptosis induced 1547 cells by Sedimentation Field-Flow Fractionation. Journal of Chromatography A. 1128(1-2). 194–202. 20 indexed citations
19.
Léger, David Y., Serge Battu, Bertrand Liagre, Jean‐Louis Beneytout, & Philippe Cardot. (2006). Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation. Analytical Biochemistry. 355(1). 19–28. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Ren Breakdown of academic impact, for papers by Yongbo Peng Breakdown of academic impact, for papers by Xuemei Huang Breakdown of academic impact, for papers by Bertrand Liagre Breakdown of academic impact, for papers by Jianfang Feng Breakdown of academic impact, for papers by Tiange Cai Breakdown of academic impact, for papers by Hui Yu Breakdown of academic impact, for papers by Jia Zhang Breakdown of academic impact, for papers by Haiyun Li Breakdown of academic impact, for papers by Chao Han
Rankless by CCL
2026